Ovarian volume: Determinants and associations with cancer among postmenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 8, 2006, Pages 1550-1554

  Sherman, Mark E ^a   Lacey, James V ^a   Buys, Saundra S ^b   Reding, Douglas J ^c   Berg, Christine D ^a   Williams, Craig ^d   Hartge, Patricia ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c MARSHFIELD CLINIC   (United States)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER RISK; CANCER SCREENING; CAUCASIAN; COLON CANCER; CONFIDENCE INTERVAL; DEMOGRAPHY; ENDOMETRIUM CANCER; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; ULTRASOUND;

AGED; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; POSTMENOPAUSE;

EID: 33748062946     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0847     Document Type: Article

References (23)

1. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
2. Potischman N, Hoover RN, Brinton LA, et al. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996;88:1127-35.
3. Zeleniuch-Jacquotte A, Akhmedkhanov A, Kato I, et al. Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer 2001;84:975-81.
4. Burkman RT. Reproductive hormones and cancer. Ovarian and colon cancer. Obstet Gynecol Clin North Am 2002;29:527-40.
5. Di Leo A, Messa C, Cavallini A, Linsalata M. Estrogens and colorectal cancer. Curr Drugs Immune Endocr Metabol Disord 2001;1:1-12.
6. Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 2003;14:75-84.
7. Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004;23:6365-78.
8. Jongen VHWM, Sluijmer AV, Heineman MJ. The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer. Maturitas 2002;43:77-85.
9. Buys SS, Partridge E, Greene MH, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial. Am J Obstet Gynecol 2005;193:1630-9.
10. Gohagan JK, Levin DL, Prorok PC, Sullivan D, editors. The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Control Clin Trials (suppl) 2000;21:251S-72S.
11. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (suppl) 2000;21:273S-309S.
12. Hartge P, Hayes R, Reding D, et al. Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors. Am J Obstet Gynecol 2000;183:1232-7.
13. Pavlik EJ, DePriest PD, Gallion HH, et al. Ovarian volume related to age. Gynecol Oncol 2000;77:410-2.
14. Pavlik EJ, Liu C, DePriest PD, et al. Relating ovarian size to age, menopausal status, and use of hormones (letter). Gynecol Oncol 2001;80:333-4.
15. Labrie F, Luu-The V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003;24:152-82.
16. Rinaudo P, Strauss JF III. Endocrine function of the postmenopausal ovary. Endocrinol Metab Clin North Am 2004;33:661-74.
17. Chubak J, Tworoger SS, Yasui Y, et al. Associations between reproductive and menstrual factors and postmenopausal androgen concentrations. J Womens Health 2005;14:704-12.
18. Sowers M, Crawford SL, Cauley JA, Stein E. Association of lipoprotein(a), insulin resistance, and reproductive hormones in a multiethnic cohort of pre- and perimenopausal women (The SWAN Study). Am J Cardiol 2003;92:533-7.
19. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 2004;150:161-71.
20. Ukkola O, Gagnon J, Rankinen T, et al. Age, body mass index, race and other determinants of steroid hormone variability: the HERITAGE Family Study. Eur J Epidemiol 2001;145:1-9.
21. Bulun SE, Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 2005;57:359-83.
22. Czernobilsky B, Lifschitz-Mercer B, Roth LM. Chapter 52: The ovary and fallopian tube. In: Silverberg SG, Dellis RA, Frable WJ, editors. Principles and practice of surgical and cytopathology. 3rd ed. New York: Churchill Livingstone; 1997. p. 2525-9.
23. Labrie F. Adrenal androgens and intracrinology. Semin Reprod Med 2004;22:299-309.